Market Growth

WINDHAM, N.H. – October 30, 2026 -- Ambulatory surgery center (ASC) volumes are projected to grow 24% over the next decade, while national workforce projections point to clinician shortages in 2027 across specialties that drive ASC case volume. Medicus Healthcare Solutions, a locum tenens and healthcare workforce company, released a report compiling industry research, national data and its own proprietary data on the trend.

Outpatient settings now handle more than 80% of surgeries

The report, titled "Ambulatory Surgery Centers: Market Growth, Workforce Pressures, and Operational Demands," finds that more than 80% of surgeries are now performed in an outpatient setting. About 90% of ASCs have some degree of physician ownership.

Maryland, Georgia, Idaho and Arizona lead on ASC density

These four states have the highest number of ASCs per 100,000 residents, according to the report.

Munich – October 29, 2026 -- Arrivals from China in Germany are forecast to rise 178% between 2026 and 2036, the steepest increase among major source markets, according to a new Accor tourism study based on Tourism Economics projections.

Other Asian markets follow closely. South Korea is expected to grow 94%, Japan 92% and India 84% over the same period.

International overnight stays in Germany to grow 29% by 2036

Demand from Asia-Pacific could climb 111%, while the Middle East is projected to rise 112%. Total tourist overnight stays in Germany are expected to increase 24%, with domestic guests contributing a 22% gain.

Spending by international guests to outpace volume with a 75% rise

Total spending by international visitors is forecast to grow 75% by 2036, well ahead of the 29% increase in their overnight stays. Category forecasts:

Boston – October 14, 2026 -- Corporate and investment banking (CIB) revenues, including nonbank financial institutions (NBFIs), are on track to reach a record $1.1 trillion in 2026, up more than 7% from 2025, according to Boston Consulting Group's 2026 Corporate and Investment Banking Report, "A Golden Window for Growth." BCG projects the total revenue pool will reach about $1.4 trillion by 2030, growing roughly 5% a year. 2026 will be the sixth consecutive year of growth.

The report, based on BCG Expand data and BCG analysis, argues that record earnings give CIB leaders a limited window to build the capabilities needed for the next growth phase. Banks are beginning to pivot from product-led to client- and platform-led models.

Delray Beach – October 13, 2026 -- The global rodenticides market is estimated at USD 6.61 billion in 2026 and is projected to reach USD 8.83 billion by 2031, a 6.0% CAGR, according to MarketsandMarkets.

North America held 31.3% of 2025 revenue as Europe is expected to keep a significant share

North America accounted for the largest regional revenue share in 2025, at 31.3%. Europe is expected to hold a significant share of the global market, driven by rising rodent infestations in urban, industrial and agricultural sectors and by stringent food safety and public health rules. Well-developed pest control services and efficient distribution systems add to its position. Asia Pacific is identified as an important growth region, supported by rapid urbanization, expanding agriculture and food-storage infrastructure.

Gwacheon, South Korea – – October 08, 2026 -- Park Systems Corp. captured 23.8% of global atomic force microscopy (AFM) revenue in 2025, retaining the top industry ranking for a fourth consecutive year from 2022 through 2025, according to QY Research's Global Atomic Force Microscopy Market Report.

Park Systems leads both revenue and unit shipments in 2025

The South Korea-based company sold 340 AFM systems during the year, the highest unit volume among manufacturers tracked in the study, while also topping the market on revenue share.

Pune, India -- October 03, 2026 -- The global sulfur market reached USD 6.56 billion in 2025 and is forecast to climb to USD 9.34 billion by 2034, a 4% compound annual growth rate, according to Maximize Market Research.

Fertilizer demand consumes more than half of recovered sulfur output

Agricultural use absorbs over 55% of recovered sulfur, primarily through phosphate fertilizer and sulfuric acid production. Nearly 98.5% of global elemental sulfur originates as a byproduct of petroleum refining, natural gas processing, coking, and metallurgical operations, tying supply directly to energy-sector output.

Delray Beach, Fla. – September 26, 2026 -- The global liquid handling system market will grow from $5.26 billion in 2026 to $7.79 billion by 2031, expanding at a compound annual growth rate of 8.2%, according to a new report from MarketsandMarkets.

Automated systems and pipettes lead segment growth

Automated systems held the largest share of the market in 2025 and are projected to post the highest CAGR of 9.0% through 2031, as pharmaceutical and biotechnology laboratories shift from manual liquid transfer to robotic platforms for pipetting, dispensing, dilution and microplate handling. Within product categories, pipettes accounted for the largest 2025 share and are forecast to grow fastest at 9.5% CAGR, driven by adoption of electronic and multi-channel pipetting systems that integrate with laboratory information management systems (LIMS) and support nanoliter-scale dispensing for genomics and cell and gene therapy workflows.

Pune, India – September 25, 2026 -- The global placenta market is set to nearly triple from USD 96.1 billion in 2025 to USD 275.18 billion by 2034, expanding at a 12.4% compound annual growth rate, according to a new analysis by Maximize Market Research.

Asia-Pacific leads global demand as Japan, South Korea and China drive placenta research

Asia-Pacific held the leading market position in 2025, backed by strong placenta research and development in Japan, South Korea and China, alongside rising production of placenta-derived products for pharmaceutical and cosmetics applications. The region's large consumer base and appetite for anti-aging and skincare solutions continue to underpin its dominant position.

Los Angeles – September 25, 2026 -- NO CAP! Soda Pop has become the No. 1 modern soda brand by both dollar sales and units sold at a national convenience retailer operating more than 2,000 stores, according to the retailer's latest 12-week SPINS data.

Brand overtakes Poppi and Olipop within six months of shelf entry

The ranking arrives less than six months after NO CAP! entered the chain, placing it ahead of modern soda rivals Poppi and Olipop at the retailer. NO CAP! also ranked No. 8 among all carbonated soft drink brands across the same network.

Co-founder cites capital disadvantage against larger rivals

"To become the No. 1 modern soda with this retail partner less than six months after hitting shelves is a huge moment for us," said Vinny Wilson, co-founder of NO CAP! Soda Pop. He noted the brand competed against companies with significantly more capital, distribution and years in the market.

Las Vegas – September 20, 2026 -- The paroxysmal nocturnal hemoglobinuria (PNH) market across the seven major markets was valued at approximately $1.5 billion in 2025 and is projected to grow at a compound annual growth rate of 7.1% through 2036, according to DelveInsight.

Regeneron's pozelimab-cemdisiran combination leads next wave of PNH therapies

Pozelimab, a fully human anti-C5 monoclonal antibody developed on Regeneron's VelocImmune platform, is expected to generate the highest revenue among emerging PNH therapies in the seven major markets. The drug is being tested in combination with Alnylam's siRNA therapy cemdisiran; Regeneron has said Phase III results in PNH are anticipated in the fourth quarter of 2026 or the first quarter of 2027.